HECHT BETH (See Remarks) sold 1.4% of their position (16.67K shares) of XERIS BIOPHARMA HOLDINGS, INC. on the open market
Open‑market sale worth $103.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/1/2026ACC: 0001652410-26-000010
Officer· See Remarks
Since Oct 2021
-16.67K
Net shares
Net seller
$103.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
16.67K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−16.67K
Price / share
$6.23
Trade value
$103.81K
% of position
1.4%
5/1/2026
1.21M→1.19M
Total
Net shares
−16.67K
Net value
-$103.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/1/2026 | S · Sale | −16.67K | $6.23 | $103.81K | 1.4% | 1.21M | 1.19M |
| Total | −16.67K | -$103.81K | ||||||
Derivative Transactions0
No derivative transactions reported